ArticleThe Lancet. Neurology2025

Prediction of amyloid and tau brain deposition and cognitive decline in people with Down syndrome using plasma biomarkers: a longitudinal cohort study.

Shorena Janelidze et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.